Comprehensive Osteopathic Medical Licensing Examination (COMLEX) Level 2 Practice Exam

In chronic Hepatitis B infections, the presence of Anti-HB e IgG (antibody to Hepatitis B e antigen) indicates a stage of low infectivity. This is because this serological marker signifies that the patient has mounted an immune response to the e antigen, which is often associated with a lower level of viral replication and, consequently, lower risk of transmission.

When the Anti-HB e IgG is found, it usually suggests that the hepatitis infection is moving toward a more controlled state, where the virus is less active. This contrasts with the presence of HB e antigen, which indicates active viral replication and higher infectivity. The other markers, HB surface antigen and Anti-HB core IgG, can indicate active virus presence or previous infection with varying implications for risk but do not specifically signal low-risk conditions as effectively as Anti-HB e IgG does.

Thus, recognizing Anti-HB e IgG as a marker of low risk is pivotal in understanding the dynamics of chronic Hepatitis B infection and informs management and treatment decisions for patients.